NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wuhan Ammunition Life-tech Co., Ltd.

Wuhan Ammunition Life-tech Co., Ltd.

Private
WuhanHealthcare & Life Scienceshttps://www.whaltglobal.com/

Last Round

Series C

Apr 28, 2022

Est. Valuation

$182.93M

Total Funding Raised

$36.95M

Company Overview

Wuhan Ammunition Life-tech Co., Ltd. is a biotechnology company that specializes in the research, development, production, and sale of non-invasive early cancer detection products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

liquid biopsycancer screeningDNA methylationearly cancer detectionmolecular diagnosticsepigeneticsPCRcell-free DNAbiomarker discoveryprecision oncologydiagnostic kitscancer blood testnon-invasive testingbioinformaticsmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wuhan Ammunition Life-tech Co., Ltd. Comparables

Compare Wuhan Ammunition Life-tech Co., Ltd. with similar companies based on industry and business-model similarity.

Wuhan Ammunition Life-tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Creative Biosciences (Guangzhou) Co., Ltd.
87%
New Horizon Health
79%
Kindstar Global
79%

Wuhan Ammunition Life-tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 28, 2022
Series BFeb 3, 2021
Series AApr 27, 2020
Early FundingJan 1, 2018

Key People

Founding team and executive leadership

Eric John

CEO

Executive Team

Wuhan Ammunition Life-tech Co., Ltd. Investors

Notable investors and investment history

Wuhan Ammunition Life-tech Co., Ltd. investors
InvestorRounds
CCB InternationalSeries C
Wuhan Gaoke State-owned Holding GroupSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2022

    $15.1M round led by CCB International

  • Apr 27, 2020

    $4.24M round led by CCB Medical Growth Fund.

Wuhan Ammunition Life-tech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wuhan Ammunition Life-tech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wuhan Ammunition Life-tech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan
Employee Range4
Year Founded2015
Last FundingApr 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.